Matches in SemOpenAlex for { <https://semopenalex.org/work/W2134328707> ?p ?o ?g. }
- W2134328707 abstract "Chorioamnionitis is a common infection that affects both mother and infant. Infant complications associated with chorioamnionitis include early neonatal sepsis, pneumonia, and meningitis. Chorioamnionitis can also result in maternal morbidity such as pelvic infection and septic shock.Clinical chorioamnionitis is estimated to occur in 1% to 2% of term births and in 5% to 10% of preterm births; histologic chorioamnionitis is found in nearly 20% of term births and in 50% of preterm births. Women with chorioamnionitis have a two to three times higher risk for cesarean delivery and a three to four times greater risk for endomyometritis, wound infection, pelvic abscess, bacteremia, and postpartum hemorrhage.To assess the effects of administering antibiotic regimens for intra-amniotic infection on maternal and perinatal morbidity and mortality and on infection-related complications.We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (1 October 2014), CENTRAL, MEDLINE, Embase, LILACS, and the WHO ICTRP (September 2014). We also searched reference lists of retrieved studies and contacted experts in the field.Randomized controlled trials (RCTs) that included women who experienced intra-amniotic infection. Trials were included if they compared antibiotic treatment with placebo or no treatment (if applicable), treatment with different antibiotic regimens, or timing of antibiotic therapy (intrapartum and/or postpartum). Therefore, this review assesses trials evaluating intrapartum antibiotics, intrapartum and postpartum antibiotic regimens, and postpartum antibiotics. Diagnosis of intra-amniotic infection was based on standard criteria (clinical/test), and no limit was placed on gestational age.Two review authors independently assessed trials for inclusion and trial quality. Two review authors independently extracted data and checked them for accuracy. We assessed the quality of the evidence using the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) approach and included a 'Summary of findings' table.Our prespecified primary outcomes were maternal and neonatal mortality, maternal and neonatal severe infection, and duration of maternal and neonatal hospital stay.We included 11 studies (involving 1296 women) and assessed them as having low to moderate risk of bias - mainly because allocation concealment methods were not adequately reported, most studies were open, and outcome reporting was incomplete. The quality of the evidence was low to very low for most outcomes, as per the GRADE approach. The following antibiotics were assessed in the included trials: ampicillin, ampicillin/sulbactam, gentamicin, clindamycin, and cefotetan. During labor: meta-analysis of two studies found no clear differences in rates of neonatal sepsis (163 neonates; risk ratio (RR) 1.07, 95% confidence interval (CI) 0.40 to 2.86; I² = 9%; low quality of evidence), treatment failure (endometritis) (163 participants; RR 0.86, 95% CI 0.27 to 2.70; I² = 0%; low quality of evidence), and postpartum hemorrhage (RR 1.39, 95% CI 0.76 to 2.56; I² = 0%; low quality of evidence) when two different dosages/regimens of gentamicin were assessed. No clear differences between groups were found for any reported maternal or neonatal outcomes. The review did not identify data for a comparison of antibiotics versus no treatment/placebo. Postpartum: meta-analysis of two studies that evaluated use of antibiotics versus placebo after vaginal delivery showed no significant differences between groups in rates of treatment failure or postpartum endometritis. No significant differences were found in rates of neonatal death and postpartum endometritis when use of antibiotics was compared with no treatment. Four trials assessing two different dosages/regimens of gentamicin or dual-agent therapy versus triple-agent therapy, or comparing antibiotics, found no significant differences in most reported neonatal or maternal outcomes; the duration of hospital stay showed a difference in favor of the group of women who received short-duration antibiotics (one study, 292 women; mean difference (MD) -0.90 days, 95% CI -1.64 to -0.16; moderate quality of evidence). Intrapartum versus postpartum: one small study (45 women) evaluating use of ampicillin/gentamicin during intrapartum versus immediate postpartum treatment found significant differences favoring the intrapartum group in the mean number of days of maternal postpartum hospital stay (one trial, 45 women; MD -1.00 days, 95% CI -1.94 to - 0.06; very low quality of evidence) and the mean number of neonatal hospital stay days (one trial, 45 neonates; MD -1.90 days, 95% CI -3.91 to -0.49; very low quality of evidence). Although no significant differences were found in the rate of maternal bacteremia or early neonatal sepsis, for the outcome of neonatal pneumonia or sepsis we observed a significant difference favoring intrapartum treatment (one trial, 45 neonates; RR 0.06, 95% CI 0.00 to 0.95; very low quality of evidence).This review included 11 studies (having low to moderate risk of bias). The quality of the evidence was low to very low for most outcomes, as per the GRADE approach. Only one outcome (duration of hospital stay) was considered to provide moderate quality of evidence when antibiotics (short duration) were compared with antibiotics (long duration) during postpartum management of intra-amniotic infection. Our main reasons for downgrading the quality of evidence were limitations in study design or execution (risk of bias), imprecision, and inconsistency of results.Currently, limited evidence is available to reveal the most appropriate antimicrobial regimen for the treatment of patients with intra-amniotic infection; whether antibiotics should be continued during the postpartum period; and which antibiotic regimen or what treatment duration should be used. Also, no evidence was found on adverse effects of the intervention (not reported in any of the included studies). One small RCT showed that use of antibiotics during the intrapartum period is superior to their use during the postpartum period in reducing the number of days of maternal and neonatal hospital stay." @default.
- W2134328707 created "2016-06-24" @default.
- W2134328707 creator A5020180402 @default.
- W2134328707 creator A5024029052 @default.
- W2134328707 creator A5042756556 @default.
- W2134328707 creator A5079649761 @default.
- W2134328707 date "2014-12-19" @default.
- W2134328707 modified "2023-10-12" @default.
- W2134328707 title "Antibiotic regimens for management of intra-amniotic infection" @default.
- W2134328707 cites W1479290061 @default.
- W2134328707 cites W1520396871 @default.
- W2134328707 cites W1549703099 @default.
- W2134328707 cites W1963891738 @default.
- W2134328707 cites W1965079852 @default.
- W2134328707 cites W1967391703 @default.
- W2134328707 cites W1968024832 @default.
- W2134328707 cites W1981718597 @default.
- W2134328707 cites W1986206473 @default.
- W2134328707 cites W1987389472 @default.
- W2134328707 cites W1991358805 @default.
- W2134328707 cites W1996161017 @default.
- W2134328707 cites W2002591986 @default.
- W2134328707 cites W2006179657 @default.
- W2134328707 cites W2010918033 @default.
- W2134328707 cites W2016370336 @default.
- W2134328707 cites W2030223994 @default.
- W2134328707 cites W2033074145 @default.
- W2134328707 cites W2040714198 @default.
- W2134328707 cites W2041321671 @default.
- W2134328707 cites W2053545398 @default.
- W2134328707 cites W2054477725 @default.
- W2134328707 cites W2066477655 @default.
- W2134328707 cites W2077550185 @default.
- W2134328707 cites W2089722112 @default.
- W2134328707 cites W2092077411 @default.
- W2134328707 cites W2107032889 @default.
- W2134328707 cites W2107116490 @default.
- W2134328707 cites W2113753366 @default.
- W2134328707 cites W2118026870 @default.
- W2134328707 cites W2134328707 @default.
- W2134328707 cites W2134920609 @default.
- W2134328707 cites W2151208989 @default.
- W2134328707 cites W2159114744 @default.
- W2134328707 cites W2166992661 @default.
- W2134328707 cites W2203708563 @default.
- W2134328707 cites W2335718861 @default.
- W2134328707 cites W2339740337 @default.
- W2134328707 cites W2407246162 @default.
- W2134328707 cites W2410351669 @default.
- W2134328707 cites W2744343135 @default.
- W2134328707 cites W3151214936 @default.
- W2134328707 cites W4230599084 @default.
- W2134328707 cites W4250279466 @default.
- W2134328707 cites W4253604782 @default.
- W2134328707 cites W4293362871 @default.
- W2134328707 doi "https://doi.org/10.1002/14651858.cd010976.pub2" @default.
- W2134328707 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25526426" @default.
- W2134328707 hasPublicationYear "2014" @default.
- W2134328707 type Work @default.
- W2134328707 sameAs 2134328707 @default.
- W2134328707 citedByCount "32" @default.
- W2134328707 countsByYear W21343287072014 @default.
- W2134328707 countsByYear W21343287072015 @default.
- W2134328707 countsByYear W21343287072016 @default.
- W2134328707 countsByYear W21343287072017 @default.
- W2134328707 countsByYear W21343287072018 @default.
- W2134328707 countsByYear W21343287072019 @default.
- W2134328707 countsByYear W21343287072020 @default.
- W2134328707 countsByYear W21343287072021 @default.
- W2134328707 countsByYear W21343287072022 @default.
- W2134328707 countsByYear W21343287072023 @default.
- W2134328707 crossrefType "reference-entry" @default.
- W2134328707 hasAuthorship W2134328707A5020180402 @default.
- W2134328707 hasAuthorship W2134328707A5024029052 @default.
- W2134328707 hasAuthorship W2134328707A5042756556 @default.
- W2134328707 hasAuthorship W2134328707A5079649761 @default.
- W2134328707 hasConcept C126322002 @default.
- W2134328707 hasConcept C131872663 @default.
- W2134328707 hasConcept C2775953899 @default.
- W2134328707 hasConcept C2777629866 @default.
- W2134328707 hasConcept C2778376644 @default.
- W2134328707 hasConcept C2778384902 @default.
- W2134328707 hasConcept C2779234561 @default.
- W2134328707 hasConcept C2781452722 @default.
- W2134328707 hasConcept C54355233 @default.
- W2134328707 hasConcept C71924100 @default.
- W2134328707 hasConcept C86803240 @default.
- W2134328707 hasConceptScore W2134328707C126322002 @default.
- W2134328707 hasConceptScore W2134328707C131872663 @default.
- W2134328707 hasConceptScore W2134328707C2775953899 @default.
- W2134328707 hasConceptScore W2134328707C2777629866 @default.
- W2134328707 hasConceptScore W2134328707C2778376644 @default.
- W2134328707 hasConceptScore W2134328707C2778384902 @default.
- W2134328707 hasConceptScore W2134328707C2779234561 @default.
- W2134328707 hasConceptScore W2134328707C2781452722 @default.
- W2134328707 hasConceptScore W2134328707C54355233 @default.
- W2134328707 hasConceptScore W2134328707C71924100 @default.
- W2134328707 hasConceptScore W2134328707C86803240 @default.
- W2134328707 hasLocation W21343287071 @default.
- W2134328707 hasLocation W21343287072 @default.